Biology is undergoing a substantial shift, as scientists now have a brand-new tool to modify our genetic code.
Advances in a technology called CRISPR — which stands for “Clustered Regularly Interspaced Short Palindromic Repeats” — offer researchers something like a set of “scissors,” so they can snip away at genetic material with the objective of treating disease, growing new crops and more.
- Synthego’s founders are ex-SpaceX, the private space company established by Elon Musk.
- They state CRISPR is a biological breakthrough that will assist scientists discover treatments for common hereditary diseases.
- Synthego wishes to assist researchers use tools like CRISPR to edit the genetic code.
2 former SpaceX engineers, Michael and Paul Dabrowski, saw a chance that cannot be missed. Neither sibling has a background in genes, however they saw a chance to utilize software to assist researchers automate their research.
” As a field, CRISPR and genome engineering is extremely at an early stage, “Synthego’s Paul Dabrowski informed us.
” This, as a computer engineer, resembles being, say, in the 1970’s with computers, where everybody had mainframes and there were very few computer users.”
READ MORE ABOUT CRISPR HERE: WHAT IS CRISPR?
LiveScience.Tech and CNBC sat down with the Dabrowskis to talk about how their start-up, called Synthego, makes it much easier for researchers to utilize tools like CRISPR to discover treatments for diseases in the next decade. Here’s what they had to state.